Tobacco industry: E-cigarettes are hot - but are they healthy?: Celebrity vapers have given a boost to a sanitised vice with sales of $3bn last year

Guardian (UK) |

"The biggest mistake was to call it an e-cigarette in the first place," declares Jacob Fuller (pictured below), gently puffing or "vaping" on a slim matt black device. Fuller, who runs Blu eCigs UK, prefers the term "vaporiser", as well he might given tobacco's status as public enemy number one. But with its sleek vaporisers, which come in flavours such as cherry and vanilla, Fuller is serving up a sanitised vice. "Like Starbucks is to coffee, we want to be that to the electronic cigarettes category," he says. For the uninitiated: e-cigarettes - invented 11 years ago in Beijing by a Chinese pharmacist - are battery-powered devices that simulate the effects of smoking by heating a nicotine liquid into vapour, which the user inhales and exhales. Other chemicals are added to create flavours. Fuller thinks the "e-cig" label stunted the huge potential of the vaporiser market but the opportunity is still a large one with global sales hitting $3bn (pounds 1.8bn) last year from a standing start in 2008. But the e-cigarette market is a drop in the ocean compared with the global tobacco industry, which is still worth more than $700bn (pounds 411bn). And competition is heating up: there are more than 400 e-cigarette brands in circulation, many of them cheap imports from China, but the big tobacco companies have started to stake a claim. Earlier this month, Japan Tobacco bought the UK firm E-Lites for an undisclosed sum while Marlboro-maker Philip Morris International, the world's largest tobacco firm, is also making a play for UK vapers with yesterday's purchase of Nicocigs, which makes Nicolites. Fuller, who hails from Toronto, is determined that Blu, his new vehicle, will be out in front setting a goal of capturing up to a quarter of the UK market by the end of this year. E-cigarette usage in Britain has tripled to two million since 2012, according to the anti-smoking group Action on Smoking and Health (ASH) with UK sales thought to have quadrupled in size to an estimated pounds 200m last year. "We plan to replicate the success of the Blu brand in the USA which, with similar levels of funding, shot from a turnover of $18m to $250m in just a year," says Fuller. Fuller's previous company Skycig was bought by US tobacco group Lorillard last year for pounds 30m, with that brand now being phased out in favour of Blu. The latter is already the biggest selling brand in the US - thanks in no small part to celebrity vapers in the shape of Leonardo di Caprio, Lindsay Lohan and Kate Moss. The company is pumping pounds 20m into this month's UK launch which is backed up by sales teams based in Edinburgh and Birmingham. It has also secured distribution deals with high street names such as WH Smith, the Co-op and Morrisons. So what is the appeal of the UK? Fuller reels off the statistics: "There are, officially, 10 million adult smokers in the UK but there must be a lot more than that, so it is a massive market. It's also very expensive to smoke here - smokers typically pay pounds 8 for a packet of 20, compared with about $10 (pounds 5.88) in New York or even less - $3.50 - in North Carolina - so we are offering smokers a cheaper and more convenient alternative." Products in the blu eCigs range are priced from pounds 14.99 for a rechargeable kit and pounds 5.99 for cartridge refills. The market is a "hugely exciting one", says Fuller, who points to technological developments that are creating better quality, more reliable products. The company that makes batteries for Samsung also makes them for Blu e-cigarettes. But some analysts argue that the entrance of big tobacco firms into the sector blurs the line between e-cigarettes and conventional tobacco. In Britain, the e-cigarette industry is already facing scrutiny from both health experts and policymakers, with pressure for a more evidence-based approach amid concerns that usage simply "normalises" smoking. Crucial to the industry's future is whether e-cigarettes are a gateway into or out of tobacco addiction - and the jury is out on that one. With plain cigarette packaging confirmed this week and tougher regulation ahead, health experts are demanding a clearer policy on e-cigarettes. Fuller says Blu's e-cigs are not being promoted or advertised as a device to stop smoking. Instead, the promotional material focuses on the product as "a lifestyle choice to give adult smokers the freedom to do what they enjoy but without being judged". But he concedes that many Skycig users opted for "dual usage" - smoking regular cigarettes at home and e-cigarettes elsewhere. That will add weight to health experts' claims that there is no evidence e-cigarette usage helps people to stop smoking. Recently, more than 100 leading public health doctors and specialists from around the world signed a letter to the director general of the World Health Organisation, Margaret Chan, calling for new controls on e-cigarettes and warning that they may be a stalking horse for the tobacco industry. They want the WHO to bring e-cigarettes under the same tight controls as tobacco products, with bans on advertising and promotion, claiming there is insufficient evidence that e-cigarettes are harmless and can help people to quit smoking. Fuller, meanwhile, predicts that the number of e-cigarette brands will drop from hundreds to fewer than 10 in short order - and Blu e-Cigs will be one of the survivors. Captions: Vaping in trendy Shoreditch at the first e-cigarette coffee shop in London. Health groups fear the new product is not used to quit cigarettes Photograph: Jane Mingay/Rex

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
SMEYF Smart Employee Benefits 0.17 0.00 0.00 0



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dr Oliver Krause Founder Untitled Inc Part 2

Matt Bird sits down with Dr Oliver Krause, Founder Untitled Inc, in part 2 of this 2 part interview at the World Economic Forum at Davos 2019

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…